Redsense Medical has secured a new order valued at SEK 15.2 million from one of the company's US distributors. The order will be delivered in partial which means an extremely strong finish to 2022 and a solid foundation
for an excellent start of 2023. The company is working with distribution and supply chain partners on establishing a delivery plan and an inventory level framework moving forward. The company has a clear focus on providing patient
safety and this order can help double down on activities" continues Pontus Nobréus.